Microfold Cells, abbreviated as M cells, are specialized epithelial cells found in the mucosa-associated lymphoid tissues (MALT) of the gastrointestinal tract. These cells play a pivotal role in the immune system by facilitating the transport of antigens and pathogens from the gut lumen to underlying immune cells. M cells possess a unique morphology characterized by a reduced microvilli-covered surface compared to neighboring enterocytes. The primary function of M cells is to sample luminal contents, including bacteria, viruses, and other particles, and present them to immune cells in Peyer's patches and other mucosa-associated lymphoid structures. This process helps initiate immune responses and the development of mucosal immunity. Exploiting M cells is of interest in drug delivery and vaccination strategies. Nanoparticles or antigens can be targeted to M cells to enhance their uptake and subsequent immune response activation. Understanding the molecular and cellular mechanisms governing M cell function is crucial for developing effective mucosal vaccines and therapies for infectious diseases. Research on M cells has revealed their involvement in various intestinal infections, inflammatory bowel diseases, and interactions with commensal microbiota. Ongoing studies continue to unravel the complexities of M cell biology, providing insights into mucosal immunology and potential therapeutic strategies for mucosal-related disorders.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States